×
About 5,550 results

ALLMedicine™ Hyperthyroidism Center

Research & Reviews  1,783 results

Beta-Blocker Toxicity
https://emedicine.medscape.com/article/813342-overview

Oct 21st, 2021 - Practice Essentials Beta-adrenergic antagonist (ie, beta-blocker) toxicity can produce clinical manifestations including bradycardia, hypotension, arrhythmias, hypothermia, hypoglycemia, and seizures (see the images below). The presentation may ra...

Patient-Reported Outcomes Following Total Thyroidectomy for Graves' Disease.
https://doi.org/10.1089/thy.2021.0285
Thyroid : Official Journal of the American Thyroid Associ... Gunn AH, Frisco N et. al.

Oct 20th, 2021 - Graves' disease accounts for ~80% of all cases of hyperthyroidism and is associated with significant morbidity and decreased quality-of-life. Understanding the association of total thyroidectomy with patient-reported quality-of-life and thyroid-sp...

Clinical Characteristics and Prognostic Factors of Atrial Fibrillation at a Tertiary Center of Pakistan - From a South-Asian Lens - a Retrospective Study.
https://clinicaltrials.gov/ct2/show/NCT05082558

Oct 19th, 2021 - It is a retrospective observational study done at Aga Khan University Hospital, Karachi, Pakistan, which is a tertiary care teaching hospital with a cardiology and cardiac surgery center. Aga Khan Hospital is one of the main referral health center...

Deliberate self-harm in a patient with hyperthyroidism with acute psychosis.
https://doi.org/10.1136/bcr-2021-242333
BMJ Case Reports; Wong HH, Pang NTP

Oct 16th, 2021 - A woman in her 30s with underlying Graves' disease, who recently completed radioactive iodine treatment, presented with 2 weeks of acutely altered behaviour associated with auditory hallucinations and religious preoccupations. Laboratory investiga...

l-Thyroxine induces left ventricular remodeling and fibrosis in rats by upregulating mi...
https://doi.org/10.1080/01480545.2021.1986251
Drug and Chemical Toxicology; Khaleel EF

Oct 14th, 2021 - miR-21 is the most studied pro-fibrotic marker in the majority of mammalian tissues. The precise mechanism by which hyperthyroidism induces left ventricular LV fibrosis and remodeling remains unclear. In this study, we have investigated the role o...

see more →

Guidelines  4 results

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/EP151038.PS
Endocrine Practice : Official Journal of the American Col... Hennessey JV, Garber JR et. al.

Feb 6th, 2016 - Hypothyroidism and hyperthyroidism can be readily diagnosed and can be treated in a safe, cost-effective manner. Professional organizations have given guidance on how and when to employ thyroid-stimulating hormone testing for the detection of thyr...

American Thyroid Association Guide to investigating thyroid hormone economy and action ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887458
Thyroid : Official Journal of the American Thyroid Associ... Bianco AC, Anderson G et. al.

Sep 5th, 2013 - An in-depth understanding of the fundamental principles that regulate thyroid hormone homeostasis is critical for the development of new diagnostic and treatment approaches for patients with thyroid disease. Important clinical practices in use tod...

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the Americ...
https://doi.org/10.4158/ep.17.3.456
Endocrine Practice : Official Journal of the American Col... Bahn RS, Burch HB et. al.

Jun 28th, 2011 - Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based ...

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the Americ...
https://doi.org/10.1089/thy.2010.0417
Thyroid : Official Journal of the American Thyroid Associ... Bahn Chair RS, Burch HB et. al.

Apr 23rd, 2011 - Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based ...

see more →

Drugs  137 results see all →

Clinicaltrials.gov  28 results

Clinical Characteristics and Prognostic Factors of Atrial Fibrillation at a Tertiary Center of Pakistan - From a South-Asian Lens - a Retrospective Study.
https://clinicaltrials.gov/ct2/show/NCT05082558

Oct 19th, 2021 - It is a retrospective observational study done at Aga Khan University Hospital, Karachi, Pakistan, which is a tertiary care teaching hospital with a cardiology and cardiac surgery center. Aga Khan Hospital is one of the main referral health center...

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study
https://clinicaltrials.gov/ct2/show/NCT05049603

Sep 20th, 2021 - Graves' orbitopathy (GO) is the most common extra-thyroidal manifestation of Graves' disease (GD). GO profoundly impairs the quality of life of affected patients. The pathogenesis is autoimmune, reflecting cross-reactivity against antigens shared ...

Thyroid Uptake Quantification on a New Generation of Gamma Camera
https://clinicaltrials.gov/ct2/show/NCT05049551

Sep 20th, 2021 - Planar and SPECT/CT scintigraphy will be performed on a new generation large field CZT gamma camera and thyroid uptake (TU) value will be calculated on planar acquisition for 23 consecutive patients referred in our department for hyperthyroidism. ...

Observation in the Treatment of Graves' Disease
https://clinicaltrials.gov/ct2/show/NCT05043233

Sep 14th, 2021 - Graves' disease is the main cause of clinically hyperthyroidism, accounting for about 75% to 80%, and it occurs in women of childbearing age. Clinical manifestations include: high eating, weight loss, sweating, palpitations, emotional excitement a...

Observational and Diagnostical Study on Transient Allostatic Responses of Thyroid Function After Cardiopulmonary Resuscitation
https://clinicaltrials.gov/ct2/show/NCT04392258

Aug 19th, 2021 - Transient allostatic responses of thyroid function are common in the critically ill. About 70% of all patients treated on intensive care units develop a so-called non-thyroidal illness syndrome (NTIS) or TACITUS (thyroid allostasis in critical ill...

see more →

News  254 results

Expert Examines Immunotherapy Potential in Small Cell Lung Cancer
https://www.onclive.com/view/expert-examines-immunotherapy-potential-in-small-cell-lung-cancer

Oct 6th, 2021 - David P. Carbone, MD, PhD Several ongoing clinical trials are examining the efficacy and safety of immunotherapy agents in patients with small cell lung cancer (SCLC), explains David P. Carbone, MD, PhD. Two early phase studies have already show...

Navigating Frontline Therapy and Treatment Beyond Progression in NSCLC
https://www.onclive.com/view/navigating-frontline-therapy-and-treatment-beyond-progression-in-nsclc

Oct 6th, 2021 - Bing Xia, MD Results of the phase III KEYNOTE-189 and IMpower150 trials showed a profound survival benefit in patients with advanced nonsquamous non—small cell lung cancer (NSCLC), when pembrolizumab (Keytruda) and atezolizumab (Tecentriq), respe...

The HPV Puzzle: Quest to Deintensify Therapy in Oropharyngeal Cancer Continues
https://www.onclive.com/view/the-hpv-puzzle-quest-to-deintensify-therapy-in-oropharyngeal-cancer-continues

Oct 6th, 2021 - Nabil F. Saba, MD After more than 2 decades of change in the epidemiology of oropharyngeal cancers, the choice of optimal treatment for patients with human papillomavirus (HPV)—positive disease remains elusive. Investigators are testing strategie...

Nivolumab Effective in Advanced Anal Cancer
https://www.onclive.com/view/nivolumab-effective-in-advanced-anal-cancer

Oct 6th, 2021 - Cathy Eng, MD Treatment with the PD-1 inhibitor nivolumab (Opdivo) resulted in an overall response rate (ORR) of 24.3% in previously treated patients with squamous cell carcinoma of the anal canal (SCCA), according to findings from a single-arm p...

Immunotherapy Combo Fails to Boost Survival in Limited-Disease SCLC
https://www.medpagetoday.com/hematologyoncology/lungcancer/94772

Sep 29th, 2021 - Consolidation therapy with nivolumab (Opdivo) plus ipilimumab (Yervoy) after chemoradiotherapy did not lead to better survival outcomes for patients with limited-disease small cell lung cancer (SCLC), the randomized phase II STIMULI trial found. W...

see more →

Patient Education  14 results see all →